1. |
车国卫, 李为民, 刘伦旭. 快速肺康复需要围手术期流程优化. 中国胸心血管外科临床杂志, 2016, 23(3): 216-220.
|
2. |
车国卫, 刘伦旭, 石应康. 加速康复外科临床应用现状与思考. 中国胸心血管外科临床杂志, 2016, 23(3): 211-215.
|
3. |
鲍珊, 苏建华, 廖虎, 等. 合并慢性阻塞性肺病和手术方式对肺癌患者术后快速康复及治疗费用的影响. 中国胸心血管外科临床杂志, 2014, 21(1): 17-20.
|
4. |
Fagundes CP, Shi Q, Vaporciyan AA, et al. Symptom recovery after thoracic surgery: Measuring patient-reported outcomes with the MD Anderson Symptom Inventory. J Thorac Cardiovasc Surg, 2015, 150(3): 613-619.
|
5. |
Liu L, Che G, Pu Q, et al. A new concept of endoscopic lung cancer resection: Single -direction thoracoscopic lobectomy. Surg Oncol, 2010, 19(2): e71-77.
|
6. |
Zhi XY, Yu JM, Shi YK. Chinese guidelines on the diagnosis and treatment of primary lung cancer (2015 version). Cancer, 2015, 121 (Suppl 17): 3165-3181.
|
7. |
韩兆杰, 宋志芳, 苏建华, 等. 单胸腔引流管在肺癌术后快速康复中的应用. 中国胸心血管外科临床杂志, 2014, 21(1): 17-20.
|
8. |
苏建华, 周渝斌, 蒲强, 等. 影响肺癌手术住院费用和快速康复的临床因素分析. 中国肺癌杂志, 2014, 17(7): 536-540.
|
9. |
Wang XS, Wang Y, Guo H, et al. Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients. Cancer, 2004, 101(8): 1890-1901.
|
10. |
Mendoza TR, Wang XS, Lu C, et al. Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. Oncologist, 2011, 16(2): 217-227.
|
11. |
史静琤, 莫显昆, 孙振球. 量表编制中内容效度指数的应用. 中南大学学报(医学版), 2012, 37(2): 49-52.
|
12. |
关守义. 克龙巴赫 α 系数研究述评. 心理科学, 2009, 32(3): 685-687.
|
13. |
孙晓军. 探索性因子分析及其在应用中存在的主要问题. 心理科学, 2005, 28(6): 162-164.
|
14. |
Roque H, Veloso A, Ferreira PL. Portuguese version of the EUROPEP questionnaire: contributions to the psychometric validation. Rev Saude Publica, 2016, 50(0): 61-67.
|
15. |
许军, 刘世霆, 胡敏燕, 等. 自测健康评定量表修订版 (SRHMSV1.0) 的条目分析. 现代康复, 2001, 5(10): 58-59.
|
16. |
李灿, 辛玲. 调查问卷的信度与效度的评价方法研究. 中国卫生统计, 2008, 25(5): 541-544.
|
17. |
Shamieh O, Khamash O, Khraisat M, et al. Impact of outpatient palliative care(PC) on symptom burden in patients with advanced cancer at a tertiary cancer center in Jordan.Support Care Cancer, 2017, 25(1): 177-183.
|
18. |
Mendoza TR, Zhao F, Cleeland CS, et al.The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group. Clin Breast Cancer, 2013, 13(5): 325-334.
|
19. |
Lange RT, Brickell TA, et al. Clinical utility of the Neuro behavioral Symptom Inventory validity scales to screen for symptom exaggeration following traumatic brain injury. J Clin Exp Neuropsychol, 2015, 37(8): 853-862.
|